 | • レポートコード：QYR2104Z4689 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、多発性嚢胞腎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（診療所、研究センター、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・多発性嚢胞腎治療の市場動向 ・企業の競争状況、市場シェア ・多発性嚢胞腎治療の種類別市場規模（ANG-3070、CIM-2、CR-8、その他） ・多発性嚢胞腎治療の用途別市場規模（診療所、研究センター、病院） ・多発性嚢胞腎治療の北米市場規模2016-2027（アメリカ、カナダ） ・多発性嚢胞腎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・多発性嚢胞腎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・多発性嚢胞腎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・多発性嚢胞腎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Angion Biomedica Corp、Aptevo Therapeutics Inc、Celgene Corp、Conatus Pharmaceuticals Inc、DiscoveryBiomed Inc、Endocyte Inc、IC-MedTech Inc、Ipsen SA、Kadmon Corp LLC、Madrigal Pharmaceuticals Inc.、ManRos Therapeutics、Metabolic Solutions Development Company LLC、Mironid Ltd） ・結論 |
Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Market
The global Polycystic Kidney Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Polycystic Kidney Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Polycystic Kidney Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Polycystic Kidney Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Polycystic Kidney Disease Treatment market.
Global Polycystic Kidney Disease Treatment Scope and Market Size
Polycystic Kidney Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polycystic Kidney Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
ANG-3070
CIM-2
CR-8
Others
Segment by Application
Clinic
Research Center
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Angion Biomedica Corp
Aptevo Therapeutics Inc
Celgene Corp
Conatus Pharmaceuticals Inc
DiscoveryBiomed Inc
Endocyte Inc
IC-MedTech Inc
Ipsen SA
Kadmon Corp LLC
Conatus Pharmaceuticals Inc
DiscoveryBiomed Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ANG-3070
1.2.3 CIM-2
1.2.4 CR-8
1.2.5 Others
1.3 Market by Application
1.3.1 Global Polycystic Kidney Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Polycystic Kidney Disease Treatment Market Perspective (2016-2027)
2.2 Polycystic Kidney Disease Treatment Growth Trends by Regions
2.2.1 Polycystic Kidney Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Polycystic Kidney Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Polycystic Kidney Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Polycystic Kidney Disease Treatment Industry Dynamic
2.3.1 Polycystic Kidney Disease Treatment Market Trends
2.3.2 Polycystic Kidney Disease Treatment Market Drivers
2.3.3 Polycystic Kidney Disease Treatment Market Challenges
2.3.4 Polycystic Kidney Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polycystic Kidney Disease Treatment Players by Revenue
3.1.1 Global Top Polycystic Kidney Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Polycystic Kidney Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Polycystic Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Polycystic Kidney Disease Treatment Revenue
3.4 Global Polycystic Kidney Disease Treatment Market Concentration Ratio
3.4.1 Global Polycystic Kidney Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polycystic Kidney Disease Treatment Revenue in 2020
3.5 Polycystic Kidney Disease Treatment Key Players Head office and Area Served
3.6 Key Players Polycystic Kidney Disease Treatment Product Solution and Service
3.7 Date of Enter into Polycystic Kidney Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polycystic Kidney Disease Treatment Breakdown Data by Type
4.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Polycystic Kidney Disease Treatment Breakdown Data by Application
5.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Polycystic Kidney Disease Treatment Market Size (2016-2027)
6.2 North America Polycystic Kidney Disease Treatment Market Size by Type
6.2.1 North America Polycystic Kidney Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Polycystic Kidney Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Polycystic Kidney Disease Treatment Market Size by Type (2016-2027)
6.3 North America Polycystic Kidney Disease Treatment Market Size by Application
6.3.1 North America Polycystic Kidney Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Polycystic Kidney Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Polycystic Kidney Disease Treatment Market Size by Application (2016-2027)
6.4 North America Polycystic Kidney Disease Treatment Market Size by Country
6.4.1 North America Polycystic Kidney Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Polycystic Kidney Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Polycystic Kidney Disease Treatment Market Size (2016-2027)
7.2 Europe Polycystic Kidney Disease Treatment Market Size by Type
7.2.1 Europe Polycystic Kidney Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Polycystic Kidney Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Polycystic Kidney Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Polycystic Kidney Disease Treatment Market Size by Application
7.3.1 Europe Polycystic Kidney Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Polycystic Kidney Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Polycystic Kidney Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Polycystic Kidney Disease Treatment Market Size by Country
7.4.1 Europe Polycystic Kidney Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Polycystic Kidney Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Polycystic Kidney Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Polycystic Kidney Disease Treatment Market Size (2016-2027)
9.2 Latin America Polycystic Kidney Disease Treatment Market Size by Type
9.2.1 Latin America Polycystic Kidney Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Polycystic Kidney Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Polycystic Kidney Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Polycystic Kidney Disease Treatment Market Size by Application
9.3.1 Latin America Polycystic Kidney Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Polycystic Kidney Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Polycystic Kidney Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Polycystic Kidney Disease Treatment Market Size by Country
9.4.1 Latin America Polycystic Kidney Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Polycystic Kidney Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polycystic Kidney Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Angion Biomedica Corp
11.1.1 Angion Biomedica Corp Company Details
11.1.2 Angion Biomedica Corp Business Overview
11.1.3 Angion Biomedica Corp Polycystic Kidney Disease Treatment Introduction
11.1.4 Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.1.5 Angion Biomedica Corp Recent Development
11.2 Aptevo Therapeutics Inc
11.2.1 Aptevo Therapeutics Inc Company Details
11.2.2 Aptevo Therapeutics Inc Business Overview
11.2.3 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Introduction
11.2.4 Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.2.5 Aptevo Therapeutics Inc Recent Development
11.3 Celgene Corp
11.3.1 Celgene Corp Company Details
11.3.2 Celgene Corp Business Overview
11.3.3 Celgene Corp Polycystic Kidney Disease Treatment Introduction
11.3.4 Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.3.5 Celgene Corp Recent Development
11.4 Conatus Pharmaceuticals Inc
11.4.1 Conatus Pharmaceuticals Inc Company Details
11.4.2 Conatus Pharmaceuticals Inc Business Overview
11.4.3 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Introduction
11.4.4 Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.4.5 Conatus Pharmaceuticals Inc Recent Development
11.5 DiscoveryBiomed Inc
11.5.1 DiscoveryBiomed Inc Company Details
11.5.2 DiscoveryBiomed Inc Business Overview
11.5.3 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Introduction
11.5.4 DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.5.5 DiscoveryBiomed Inc Recent Development
11.6 Endocyte Inc
11.6.1 Endocyte Inc Company Details
11.6.2 Endocyte Inc Business Overview
11.6.3 Endocyte Inc Polycystic Kidney Disease Treatment Introduction
11.6.4 Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.6.5 Endocyte Inc Recent Development
11.7 IC-MedTech Inc
11.7.1 IC-MedTech Inc Company Details
11.7.2 IC-MedTech Inc Business Overview
11.7.3 IC-MedTech Inc Polycystic Kidney Disease Treatment Introduction
11.7.4 IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.7.5 IC-MedTech Inc Recent Development
11.8 Ipsen SA
11.8.1 Ipsen SA Company Details
11.8.2 Ipsen SA Business Overview
11.8.3 Ipsen SA Polycystic Kidney Disease Treatment Introduction
11.8.4 Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.8.5 Ipsen SA Recent Development
11.9 Kadmon Corp LLC
11.9.1 Kadmon Corp LLC Company Details
11.9.2 Kadmon Corp LLC Business Overview
11.9.3 Kadmon Corp LLC Polycystic Kidney Disease Treatment Introduction
11.9.4 Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.9.5 Kadmon Corp LLC Recent Development
11.10 Madrigal Pharmaceuticals Inc.
11.10.1 Madrigal Pharmaceuticals Inc. Company Details
11.10.2 Madrigal Pharmaceuticals Inc. Business Overview
11.10.3 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Introduction
11.10.4 Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.10.5 Madrigal Pharmaceuticals Inc. Recent Development
11.11 ManRos Therapeutics
11.11.1 ManRos Therapeutics Company Details
11.11.2 ManRos Therapeutics Business Overview
11.11.3 ManRos Therapeutics Polycystic Kidney Disease Treatment Introduction
11.11.4 ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.11.5 ManRos Therapeutics Recent Development
11.12 Metabolic Solutions Development Company LLC
11.12.1 Metabolic Solutions Development Company LLC Company Details
11.12.2 Metabolic Solutions Development Company LLC Business Overview
11.12.3 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Introduction
11.12.4 Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.12.5 Metabolic Solutions Development Company LLC Recent Development
11.13 Mironid Ltd
11.13.1 Mironid Ltd Company Details
11.13.2 Mironid Ltd Business Overview
11.13.3 Mironid Ltd Polycystic Kidney Disease Treatment Introduction
11.13.4 Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2016-2021)
11.13.5 Mironid Ltd Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ANG-3070
Table 3. Key Players of CIM-2
Table 4. Key Players of CR-8
Table 5. Key Players of Others
Table 6. Global Polycystic Kidney Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Polycystic Kidney Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Polycystic Kidney Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Polycystic Kidney Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Polycystic Kidney Disease Treatment Market Share by Regions (2022-2027)
Table 12. Polycystic Kidney Disease Treatment Market Trends
Table 13. Polycystic Kidney Disease Treatment Market Drivers
Table 14. Polycystic Kidney Disease Treatment Market Challenges
Table 15. Polycystic Kidney Disease Treatment Market Restraints
Table 16. Global Polycystic Kidney Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Polycystic Kidney Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Kidney Disease Treatment as of 2020)
Table 19. Ranking of Global Top Polycystic Kidney Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Polycystic Kidney Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Polycystic Kidney Disease Treatment Product Solution and Service
Table 23. Date of Enter into Polycystic Kidney Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Polycystic Kidney Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Polycystic Kidney Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Polycystic Kidney Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Polycystic Kidney Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Polycystic Kidney Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Polycystic Kidney Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Polycystic Kidney Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Polycystic Kidney Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Polycystic Kidney Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Polycystic Kidney Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Polycystic Kidney Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Polycystic Kidney Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Polycystic Kidney Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Polycystic Kidney Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Polycystic Kidney Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Polycystic Kidney Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Polycystic Kidney Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Polycystic Kidney Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Polycystic Kidney Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Polycystic Kidney Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Polycystic Kidney Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Polycystic Kidney Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Angion Biomedica Corp Company Details
Table 64. Angion Biomedica Corp Business Overview
Table 65. Angion Biomedica Corp Polycystic Kidney Disease Treatment Product
Table 66. Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. Angion Biomedica Corp Recent Development
Table 68. Aptevo Therapeutics Inc Company Details
Table 69. Aptevo Therapeutics Inc Business Overview
Table 70. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Product
Table 71. Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. Aptevo Therapeutics Inc Recent Development
Table 73. Celgene Corp Company Details
Table 74. Celgene Corp Business Overview
Table 75. Celgene Corp Polycystic Kidney Disease Treatment Product
Table 76. Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. Celgene Corp Recent Development
Table 78. Conatus Pharmaceuticals Inc Company Details
Table 79. Conatus Pharmaceuticals Inc Business Overview
Table 80. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Product
Table 81. Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. Conatus Pharmaceuticals Inc Recent Development
Table 83. DiscoveryBiomed Inc Company Details
Table 84. DiscoveryBiomed Inc Business Overview
Table 85. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Product
Table 86. DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. DiscoveryBiomed Inc Recent Development
Table 88. Endocyte Inc Company Details
Table 89. Endocyte Inc Business Overview
Table 90. Endocyte Inc Polycystic Kidney Disease Treatment Product
Table 91. Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Endocyte Inc Recent Development
Table 93. IC-MedTech Inc Company Details
Table 94. IC-MedTech Inc Business Overview
Table 95. IC-MedTech Inc Polycystic Kidney Disease Treatment Product
Table 96. IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. IC-MedTech Inc Recent Development
Table 98. Ipsen SA Company Details
Table 99. Ipsen SA Business Overview
Table 100. Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 101. Ipsen SA Recent Development
Table 102. Kadmon Corp LLC Company Details
Table 103. Kadmon Corp LLC Business Overview
Table 104. Kadmon Corp LLC Polycystic Kidney Disease Treatment Product
Table 105. Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 106. Kadmon Corp LLC Recent Development
Table 107. Madrigal Pharmaceuticals Inc. Company Details
Table 108. Madrigal Pharmaceuticals Inc. Business Overview
Table 109. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Product
Table 110. Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 111. Madrigal Pharmaceuticals Inc. Recent Development
Table 112. ManRos Therapeutics Company Details
Table 113. ManRos Therapeutics Business Overview
Table 114. ManRos Therapeutics Polycystic Kidney Disease Treatment Product
Table 115. ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 116. ManRos Therapeutics Recent Development
Table 117. Metabolic Solutions Development Company LLC Company Details
Table 118. Metabolic Solutions Development Company LLC Business Overview
Table 119. Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Product
Table 120. Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 121. Metabolic Solutions Development Company LLC Recent Development
Table 122. Mironid Ltd Company Details
Table 123. Mironid Ltd Business Overview
Table 124. Mironid Ltd Polycystic Kidney Disease Treatment Product
Table 125. Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2016-2021) & (US$ Million)
Table 126. Mironid Ltd Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polycystic Kidney Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. ANG-3070 Features
Figure 3. CIM-2 Features
Figure 4. CR-8 Features
Figure 5. Others Features
Figure 6. Global Polycystic Kidney Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Clinic Case Studies
Figure 8. Research Center Case Studies
Figure 9. Hospital Case Studies
Figure 10. Polycystic Kidney Disease Treatment Report Years Considered
Figure 11. Global Polycystic Kidney Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Polycystic Kidney Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Polycystic Kidney Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Polycystic Kidney Disease Treatment Market Share by Regions (2022-2027)
Figure 15. Global Polycystic Kidney Disease Treatment Market Share by Players in 2020
Figure 16. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Kidney Disease Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Polycystic Kidney Disease Treatment Revenue in 2020
Figure 18. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Polycystic Kidney Disease Treatment Market Share by Type (2016-2027)
Figure 22. North America Polycystic Kidney Disease Treatment Market Share by Application (2016-2027)
Figure 23. North America Polycystic Kidney Disease Treatment Market Share by Country (2016-2027)
Figure 24. United States Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Polycystic Kidney Disease Treatment Market Share by Type (2016-2027)
Figure 28. Europe Polycystic Kidney Disease Treatment Market Share by Application (2016-2027)
Figure 29. Europe Polycystic Kidney Disease Treatment Market Share by Country (2016-2027)
Figure 30. Germany Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Polycystic Kidney Disease Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Polycystic Kidney Disease Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Polycystic Kidney Disease Treatment Market Share by Region (2016-2027)
Figure 40. China Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Polycystic Kidney Disease Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Polycystic Kidney Disease Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Polycystic Kidney Disease Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Polycystic Kidney Disease Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Polycystic Kidney Disease Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Polycystic Kidney Disease Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Polycystic Kidney Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Angion Biomedica Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 60. Aptevo Therapeutics Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 61. Celgene Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 62. Conatus Pharmaceuticals Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 63. DiscoveryBiomed Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 64. Endocyte Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 65. IC-MedTech Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 66. Ipsen SA Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 67. Kadmon Corp LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 68. Madrigal Pharmaceuticals Inc. Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 69. ManRos Therapeutics Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 70. Metabolic Solutions Development Company LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 71. Mironid Ltd Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の慢性腎臓病（CKD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…- 世界の多嚢胞性卵巣症候群治療市場規模・現状・予測（2021年-2027年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…
- 世界の多嚢胞性卵巣症候群（PCOS）治療市場規模・現状・予測（2021年-2027年） Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Women with PCOS may have infrequent or prolonged menstrual periods or excess male hormone (androgen) levels. The ovaries may develop numerous small collections of fluid (follicles) and fail to regularly r…
- 世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年） Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer. Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. Market Analysi…
- 世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年） Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer. Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. Market Analysi…